TE_12695
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSx1 |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | SPZ1, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 211.89 |
| Counts of samples | TCGA_tumor:187; TCGA_normal:0; GTEx:0 |
| TSS | chr5(+):80308951 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_12695.1 | - | Intergenic | Non-coding | Non-coding | chr5(+):80308952,80309404,80351154,80351174 |
| teRNA_12695.2 | SPZ1 | Chimeric | Non-coding | Non-coding | chr5(+):80308952,80309404,80320137,80320157 |
| teRNA_12695.3 | - | Intergenic | Non-coding | Non-coding | chr5(+):80308952,80309404,80311657,80311677 |
| teRNA_12695.4 | SPZ1 | Chimeric | Non-coding | Non-coding | chr5(+):80308952,80309404,80315338,80315421,80320137,80320157 |
| teRNA_12695.5 | - | Intergenic | Non-coding | Non-coding | chr5(+):80308952,80309271,80351154,80351174 |
| teRNA_12695.6 | SPZ1 | Chimeric | Non-coding | Non-coding | chr5(+):80308952,80309271,80320137,80320157 |
| teRNA_12695.7 | SPZ1 | Chimeric | Non-coding | Non-coding | chr5(+):80308952,80309271,80315338,80315465,80320137,80320157 |
| teRNA_12695.8 | SPZ1 | Chimeric | Non-coding | Non-coding | chr5(+):80308952,80309271,80315338,80315421,80320137,80320157 |
| teRNA_12695.9 | - | Intergenic | Non-coding | Non-coding | chr5(+):80308952,80309271,80327148,80327168 |
| teRNA_12695.10 | - | Intergenic | Non-coding | Non-coding | chr5(+):80308952,80309271,80311657,80311677 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
